Results 251 to 260 of about 124,423 (315)

Redefining the role of the transfusion medicine physician in the era of advanced cellular therapies

Transfusion, EarlyView.
Eric A. Gehrie, Kevin J. Land
wiley   +1 more source

The Role of Invasive Procedures in the Treatment of Complicated Gastrointestinal Graft‐Versus‐Host Disease in Pediatric Patients

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Background Gastrointestinal graft‐versus‐host disease (GI GVHD) following hematopoietic stem cell transplant is typically managed with medical therapy, but surgery and angioembolization may be warranted in selected cases with life‐threatening complications.
Gaia Brunetti, Giorgio Persano, Chiara Grimaldi, Pier Luigi Di Paolo, Carmen Malaspina, Francesco Quagliarella, Valerio Balassone, Anna Chiara Iolanda Contini, Gian Luigi Natali, Rita Alaggio, Ivan Pietro Aloi, Tamara Caldaro, Alessandro Crocoli   +12 more
wiley   +1 more source

Durable MRD-Negative Remission With Blinatumomab and Venetoclax in Heavily Pretreated Relapsed/Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. [PDF]

EJHaem
Qadir MS, Farooq S, Jamy O.
europepmc   +1 more source

Two Faces of NOTCH1 in Childhood Lymphoblastic T‐Cell Neoplasia: Prognostic Divergence of Mutational and Structural Aberrations

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT In pediatric patients, T‐cell lymphoblastic lymphoma (T‐LBL) survival exceeds 80%. Relapse remains associated with limited curative options. Frontline treatment is largely extrapolated from T‐cell acute lymphoblastic leukemia (T‐ALL) treatment, reflecting the ongoing debate, whether both entities represent distinct diseases or variants within ...
Marie C. Heider, Amelie Alfert, Marc Hotfilder, Birgit Burkardt, Marcel te Vrugt   +4 more
wiley   +1 more source

Pharmacological inhibition of sclerostin protects bone from B-cell acute lymphoblastic leukemia-mediated destruction. [PDF]

Hemasphere
Kuek V, Oommen J, Ferrari E, Yuan J, Economides AN, Lock RB, Malinge S, Kotecha RS, Cheung LC.   +8 more
europepmc   +1 more source

Chromosome 15q deletions confer inferior outcomes among children with ETV6::RUNX1 B-cell acute lymphoblastic leukemia. [PDF]

Blood Adv
Wang'ondu R, Kairalla JA, Shago M, Angiolillo AL, Breidenbach H, Burke MJ, Carroll AJ, Rabin KR, Salzer WL, Schore RJ, Wang C, Hunger SP, Teachey DT, Raetz EA, Loh ML, Davis KL, Rau RE.   +16 more
europepmc   +1 more source

Severe Hypercalcemia Revealing Acute Lymphoblastic Leukemia: A Case Report. [PDF]

Cureus
Maach I, El Achiwi MM, Ryouni K, Mounia EA, Benajiba N.   +4 more
europepmc   +1 more source

Ectopic expression of BEX genes in T-cell acute lymphoblastic leukemia. [PDF]

Blood Adv
Quessada J, Nozais M, Grosjean C, Savey C, Pankaew S, Allelova S, Potier D, Loosveld M, Payet-Bornet D.   +8 more
europepmc   +1 more source

Combination of p-STAT5, CRLF2 and copy number alterations as a potential indicator of a high-risk subgroup of acute lymphoblastic leukemia. [PDF]

Discov Oncol
Rasekh EO, Saleh M, Hanafy M, Basha S, Almuslimani AM, Madney Y, Abd El-Fattah R, Kamel AM.   +7 more
europepmc   +1 more source